Biotech / Pharma
TwoStep Therapeutics
Biotech / Pharma
TwoStep Therapeutics, focused on peptide-drug conjugates for tumor treatment, received $62.5 million Series A led by Insight Partners and Medical Excellence Capital.
Founded
Region
Investors
People